Spruce Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SPRB Nasdaq 8731 http://www.sprucebiosciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spruce Biosciences Inc

Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors - May 25th, 2023 12:00 pm
Spruce Biosciences to Participate in the Jefferies Healthcare Conference - May 24th, 2023 8:05 pm
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala - May 22nd, 2023 1:30 pm
Investors in Spruce Biosciences (NASDAQ:SPRB) have seen decent returns of 63% over the past year - May 16th, 2023 10:18 am
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates - May 15th, 2023 12:00 pm
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - May 4th, 2023 8:05 pm
Spruce Biosciences to Participate in May Investor Conferences - May 2nd, 2023 8:05 pm
Spruce Biosciences, Inc. (SPRB) Upgraded to Buy: Here's What You Should Know - Mar 31st, 2023 4:00 pm
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates - Mar 16th, 2023 8:00 pm
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference - Feb 28th, 2023 9:05 pm
2 “Strong Buy” Penny Stocks With Multibagger Potential - Feb 23rd, 2023 3:43 pm
Eyeing treatment of hormonal disorder, Peninsula company lays $53 million PIPE - Feb 10th, 2023 1:00 pm
Spruce Biosciences Announces $53.6 Million Private Placement Financing - Feb 9th, 2023 1:00 pm
Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference - Feb 1st, 2023 9:05 pm
Spruce Biosciences, Inc. (SPRB) Now Trades Above Golden Cross: Time to Buy? - Jan 31st, 2023 2:55 pm
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023 - Jan 9th, 2023 1:05 pm
Two Covid-era biotech IPOs — Spruce and Graphite Bio — see stock head in different directions - Jan 6th, 2023 10:54 pm
Spruce Biosciences Shares Skyrocket After Licensing Pact For Lead Program - Jan 6th, 2023 11:16 am
Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan - Jan 5th, 2023 9:00 pm
JMP Says Forgotten Spruce Biosciences Could Draw Attention In 2023 - Nov 16th, 2022 6:13 pm